Arvelle Announces Partnership with Durbin Across Europe
August 17, 2020 01:00 ET
|
Arvelle Therapeutics
Arvelle Announces Partnership with Durbin Across Europe Zug, Switzerland, 17 August 2020 – Arvelle Therapeutics, an emerging biopharmaceutical company focused on bringing innovative treatments to...
Arvelle Announces Closing of Final Tranche of Series A Financing Round
May 26, 2020 07:00 ET
|
Arvelle Therapeutics
Arvelle Announces Closing of Final Tranche of Series A Financing Round Brings the total financing to $207.8m Triggered by successful filing and validation of the MAA for cenobamate Zug,...
Arvelle Announces Closing of Final Tranche of Series A Financing Round
May 26, 2020 02:00 ET
|
Arvelle Therapeutics
Arvelle Announces Closing of Final Tranche of Series A Financing Round Brings the total financing to $207.8m Triggered by successful filing and validation of the MAA for cenobamate Zug,...
Arvelle Therapeutics: SK Life Science, Inc. Announces US Availability of XCOPRI® (cenobamate tablets) for the Treatment of Partial (Focal) Onset Seizures in Adults with Epilepsy
May 12, 2020 03:00 ET
|
Arvelle Therapeutics
SK Life Science, Inc. Announces US Availability of XCOPRI® (cenobamate tablets) for the Treatment of Partial (Focal) Onset Seizures in Adults with Epilepsy- Arvelle Therapeutics has...
Appointment of Dr Otto Schwarz as Independent Director and Chairman of the Board
December 04, 2019 02:00 ET
|
Arvelle Therapeutics
Appointment of Dr Otto Schwarz as Independent Director and Chairman of the Board Zug, Switzerland, December 4, 2019 - Arvelle Therapeutics GmbH (“Arvelle”), an emerging biopharmaceutical company...
Arvelle to Present at Jefferies 2019 London Healthcare Conference
November 15, 2019 02:00 ET
|
Arvelle Therapeutics
Arvelle to Present at Jefferies 2019 London Healthcare Conference Zug, Switzerland, November 15, 2019 - Arvelle Therapeutics GmbH (“Arvelle”), an emerging biopharmaceutical company focused on...
Arvelle Therapeutics Strengthens Management Team with Key New Hires
October 31, 2019 02:00 ET
|
Arvelle Therapeutics
Arvelle Therapeutics Strengthens Management Team with Key New Hires Appoints Petra Molan as Senior Vice President Commercial and Enrico Dolfini as...